Company / EPS (Basic)
CHINA PHARMA HOLDINGS, INC. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.71
FY2025
5-year range
-$3.78 / -$0.74
FY2022-FY2025
Trend
-197.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-3.78 to $-2.71 over the past 2 years.
Based on SEC 10-K filings.
-2.71 in FY2025.
Improved from $-3.78 to $-2.71 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 197.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.71 | -197.8% |
| FY2024 | -$0.91 | +75.9% |
| FY2023 | -$3.78 | -410.8% |
| FY2022 | -$0.74 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026